In June, both COVID-19 cases and tests in hospitals decreased in the United States. COVID-19 testing, including nucleic acid amplification tests (NAATs) and antigen tests, has reduced significantly in hospitals in the United States, according to GlobalData. As a result, COVID-19 testing has probably moved to over-the-counter antigen testing at home.
On the other hand, Abbott cut its full-year 2021 guidance on June 1 after reporting a steep drop in demand for COVID-19 testing, rapid tests. Abbott is the top market participant in the United States for COVID-19 testing, according to GlobalData. In addition, according to the CDC, 48.7% of the overall population has been fully vaccinated; thus, a considerable reduction in new cases is expected, as well as COVID-19 testing.
According to the Washington Post, unvaccinated people continue to have high case and death rates, with COVID-19 instances among the unvaccinated being 69 percent higher than national averages, even though COVID-19 cases are dropping in general. In addition, although the number of COVID-19 tests performed in the United States decreased in the first half of 2021, the combination of the delta variant as the significant COVID-19 strain, a plateau in the vaccination rate, and new cases on the rise, according to GlobalData, may result in a resurgence of COVID-19 testing.